Morgan Stanley’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$72.2K Sell
32,095
-3,730
-10% -$8.39K ﹤0.01% 6237
2025
Q1
$76.7K Buy
35,825
+1,192
+3% +$2.55K ﹤0.01% 6129
2024
Q4
$83.8K Sell
34,633
-10,020
-22% -$24.2K ﹤0.01% 6124
2024
Q3
$109K Sell
44,653
-781
-2% -$1.91K ﹤0.01% 5974
2024
Q2
$117K Buy
45,434
+725
+2% +$1.86K ﹤0.01% 5910
2024
Q1
$131K Sell
44,709
-83,775
-65% -$245K ﹤0.01% 5885
2023
Q4
$297K Buy
128,484
+67,970
+112% +$157K ﹤0.01% 5796
2023
Q3
$158K Buy
60,514
+16,724
+38% +$43.6K ﹤0.01% 5691
2023
Q2
$157K Sell
43,790
-240,346
-85% -$860K ﹤0.01% 5747
2023
Q1
$619K Sell
284,136
-32,255
-10% -$70.3K ﹤0.01% 5130
2022
Q4
$3.81M Sell
316,391
-210,715
-40% -$2.53M ﹤0.01% 3985
2022
Q3
$3.42M Sell
527,106
-159,745
-23% -$1.04M ﹤0.01% 3997
2022
Q2
$3.15M Buy
686,851
+92,823
+16% +$425K ﹤0.01% 4167
2022
Q1
$5.14M Buy
594,028
+207,408
+54% +$1.79M ﹤0.01% 3661
2021
Q4
$5.52M Buy
386,620
+266,615
+222% +$3.81M ﹤0.01% 3618
2021
Q3
$2.64M Buy
120,005
+37,339
+45% +$820K ﹤0.01% 4346
2021
Q2
$1.11M Buy
82,666
+69,210
+514% +$927K ﹤0.01% 5022
2021
Q1
$137K Buy
13,456
+5,240
+64% +$53.4K ﹤0.01% 5858
2020
Q4
$35K Buy
8,216
+2,475
+43% +$10.5K ﹤0.01% 6266
2020
Q3
$15K Sell
5,741
-854
-13% -$2.23K ﹤0.01% 6150
2020
Q2
$23K Buy
6,595
+159
+2% +$555 ﹤0.01% 5975
2020
Q1
$19K Sell
6,436
-16,739
-72% -$49.4K ﹤0.01% 5832
2019
Q4
$120K Sell
23,175
-7,622
-25% -$39.5K ﹤0.01% 5591
2019
Q3
$98K Buy
30,797
+2,545
+9% +$8.1K ﹤0.01% 5450
2019
Q2
$101K Buy
28,252
+1,551
+6% +$5.55K ﹤0.01% 5317
2019
Q1
$97K Sell
26,701
-1,693
-6% -$6.15K ﹤0.01% 5409
2018
Q4
$85K Sell
28,394
-1,040
-4% -$3.11K ﹤0.01% 5607
2018
Q3
$143K Sell
29,434
-5
-0% -$24 ﹤0.01% 5581
2018
Q2
$219K Sell
29,439
-4,448
-13% -$33.1K ﹤0.01% 5498
2018
Q1
$220K Sell
33,887
-2,107
-6% -$13.7K ﹤0.01% 5429
2017
Q4
$324K Buy
35,994
+21,228
+144% +$191K ﹤0.01% 5213
2017
Q3
$147K Buy
14,766
+2,131
+17% +$21.2K ﹤0.01% 5466
2017
Q2
$98K Sell
12,635
-397
-3% -$3.08K ﹤0.01% 5642
2017
Q1
$80K Sell
13,032
-2,828
-18% -$17.4K ﹤0.01% 5681
2016
Q4
$97K Sell
15,860
-179
-1% -$1.1K ﹤0.01% 5581
2016
Q3
$117K Sell
16,039
-22,453
-58% -$164K ﹤0.01% 5248
2016
Q2
$321K Buy
38,492
+34,683
+911% +$289K ﹤0.01% 4691
2016
Q1
$25K Buy
3,809
+500
+15% +$3.28K ﹤0.01% 5851
2015
Q4
$28K Sell
3,309
-2,286
-41% -$19.3K ﹤0.01% 5928
2015
Q3
$30K Buy
5,595
+1,073
+24% +$5.75K ﹤0.01% 5915
2015
Q2
$26K Buy
4,522
+804
+22% +$4.62K ﹤0.01% 6065
2015
Q1
$24K Sell
3,718
-4,105
-52% -$26.5K ﹤0.01% 6005
2014
Q4
$36K Sell
7,823
-1,392
-15% -$6.41K ﹤0.01% 5900
2014
Q3
$74K Sell
9,215
-4,158
-31% -$33.4K ﹤0.01% 5590
2014
Q2
$129K Sell
13,373
-12,924
-49% -$125K ﹤0.01% 5377
2014
Q1
$310K Buy
26,297
+14,356
+120% +$169K ﹤0.01% 4871
2013
Q4
$184K Buy
+11,941
New +$184K ﹤0.01% 5066